Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine ; volume:4 ; number:1 ; day:31 ; month:8 ; year:2004 ; pages:1-8 ; date:12.2004
BMC infectious diseases ; 4, Heft 1 (31.8.2004), 1-8, 12.2004
- Creator
-
Santos, Eneida A.
- Contributor
-
Sucupira, Michel VF
Arabe, Juçara
Gomes, Selma A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-4-29
- URN
-
urn:nbn:de:1111-2016030246017
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.0009, 6:05 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Santos, Eneida A.
- Sucupira, Michel VF
- Arabe, Juçara
- Gomes, Selma A.
- SpringerLink (Online service)
Other Objects (12)
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Can Urine Lamivudine Be Used to Monitor Antiretroviral Treatment Adherence?
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Treatment effects of the differential first-line antiretroviral regimens among HIV/HBV coinfected patients in southwest China: an observational study
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Can Urine Lamivudine Be Used to Monitor Antiretroviral Treatment Adherence?
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Treatment effects of the differential first-line antiretroviral regimens among HIV/HBV coinfected patients in southwest China: an observational study
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
Hepatitis B virus (HBV) genotype distribution and lamivudine-resistant mutations in HIV/HBV co-infected patients attending a Parisian hospital
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
Investigating factors associated to HBV/HIV co-infected patients in antiretroviral treatment clinic, in Northeast Ethiopia
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Can Urine Lamivudine Be Used to Monitor Antiretroviral Treatment Adherence?
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV